EDGAR Filing Documents for 0001493152-17-003796

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001493152-17-003796

Filing Date

2017-04-13

Accepted

2017-04-12 17:43:42

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		sc13g.htm	SC 13G	83931
	Complete submission text file	0001493152-17-003796.txt		85227

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733

Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-81115 | Film No.: 17758778
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 PHEASANT RUN SETAUKET NY 11733

Business Address

Bahl Lalit Rai (Filed by) CIK: 0001703504 (see all company filings)

Type: SC 13G